| Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection TA Wagner, S McLaughlin, K Garg, CYK Cheung, BB Larsen, S Styrchak, ... Science 345 (6196), 570-573, 2014 | 716 | 2014 |
| Immune clearance of highly pathogenic SIV infection SG Hansen, MP Jr, AB Ventura, CM Hughes, RM Gilbride, JC Ford, ... Nature 502 (7469), 100-104, 2013 | 705 | 2013 |
| B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers Y Fukazawa, R Lum, AA Okoye, H Park, K Matsuda, JY Bae, SI Hagen, ... Nature medicine 21 (2), 132-139, 2015 | 527 | 2015 |
| Cytomegalovirus Vectors Violate CD8+ T Cell Epitope Recognition Paradigms SG Hansen, JB Sacha, CM Hughes, JC Ford, BJ Burwitz, I Scholz, ... Science 340 (6135), 1237874, 2013 | 513 | 2013 |
| Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2 M Rolland, PT Edlefsen, BB Larsen, S Tovanabutra, E Sanders-Buell, ... Nature 490 (7420), 417-420, 2012 | 488 | 2012 |
| Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies A deCamp, P Hraber, RT Bailer, MS Seaman, C Ochsenbauer, J Kappes, ... Journal of virology 88 (5), 2489-2507, 2014 | 325 | 2014 |
| Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine SG Hansen, DE Zak, G Xu, JC Ford, EE Marshall, D Malouli, RM Gilbride, ... Nature medicine 24 (2), 130-143, 2018 | 244 | 2018 |
| Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines Y Fukazawa, H Park, MJ Cameron, F Lefebvre, R Lum, N Coombes, ... Nature medicine 18 (11), 1673-1681, 2012 | 174 | 2012 |
| Global profiling of Shewanella oneidensis MR-1: Expression of hypothetical genes and improved functional annotations E Kolker, AF Picone, MY Galperin, MF Romine, R Higdon, KS Makarova, ... Proceedings of the National Academy of Sciences 102 (6), 2099-2104, 2005 | 142 | 2005 |
| Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound AA Okoye, SG Hansen, M Vaidya, Y Fukazawa, H Park, DM Duell, R Lum, ... Nature medicine 24 (9), 1430-1440, 2018 | 124 | 2018 |
| FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial SS Li, PB Gilbert, GD Tomaras, G Kijak, G Ferrari, R Thomas, CW Pyo, ... The Journal of clinical investigation 124 (9), 3879-3890, 2014 | 119 | 2014 |
| A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge SG Hansen, EE Marshall, D Malouli, AB Ventura, CM Hughes, E Ainslie, ... Science translational medicine 11 (501), eaaw2607, 2019 | 89 | 2019 |
| Analysis of HLA A* 02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial AJ Gartland, S Li, J McNevin, GD Tomaras, R Gottardo, H Janes, Y Fong, ... Journal of virology 88 (15), 8242-8255, 2014 | 72 | 2014 |
| Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial PT Edlefsen, M Rolland, T Hertz, S Tovanabutra, AJ Gartland, ... PLoS computational biology 11 (2), e1003973, 2015 | 58 | 2015 |
| Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials M Juraska, CA Magaret, J Shao, LN Carpp, AJ Fiore-Gartland, ... Proceedings of the National Academy of Sciences 115 (36), E8378-E8387, 2018 | 56 | 2018 |
| Early cellular innate immune responses drive Zika viral persistence and tissue tropism in pigtail macaques MA O’Connor, J Tisoncik-Go, TB Lewis, CJ Miller, D Bratt, CR Moats, ... Nature communications 9 (1), 3371, 2018 | 54 | 2018 |
| Vaccine-induced human antibodies specific for the third variable region of HIV-1 gp120 impose immune pressure on infecting viruses S Zolla-Pazner, PT Edlefsen, M Rolland, XP Kong, A deCamp, R Gottardo, ... EBioMedicine 1 (1), 37-45, 2014 | 53 | 2014 |
| Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition PB Gilbert, Y Huang, AC deCamp, S Karuna, Y Zhang, CA Magaret, ... Nature Medicine 28 (9), 1924-1932, 2022 | 47 | 2022 |
| Addendum: Immune clearance of highly pathogenic SIV infection SG Hansen, M Piatak, AB Ventura, CM Hughes, RM Gilbride, JC Ford, ... Nature 547 (7661), 123-124, 2017 | 40 | 2017 |
| Sieve analysis in HIV-1 vaccine efficacy trials PT Edlefsen, PB Gilbert, M Rolland Current opinion in HIV and AIDS 8 (5), 432-436, 2013 | 38 | 2013 |
